Optimizing H. Pylori Eradication Regimen Under Intensified Acid Suppression

NCT07750938 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

316

Enrollment

OTHER

Sponsor class

Conditions

HELICOBACTER PYLORI INFECTIONS

Interventions

DRUG: Keverprazan Hydrochloride 20 mg TID
DRUG: Minocycline 100 mg (10-Day Regimen)
DRUG: Keverprazan Hydrochloride 20 mg BID
DRUG: Bismuth Potassium Citrate 240 mg
DRUG: Amoxicillin 1000 mg
DRUG: Minocycline 100 mg (14-Day Regimen)

Sponsor

Qilu Hospital of Shandong University